National Institute of Allergy and Infectious Diseases-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2017

  1. Optimizing research to speed up availability of pediatric antiretroviral drugs and formulations

    Clinical Infectious Diseases, Vol. 64, Núm. 11, pp. 1597-1603

2011

  1. First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: An open-label, randomised phase 2/3 trial

    The Lancet Infectious Diseases, Vol. 11, Núm. 4, pp. 273-283